Clinical Trial Update: Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Bryostatin 1 in combination with Paclitaxel for locally advanced or metastatic esophageal or gastric cancer; the trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED